Latest Cholangiocarcinoma Stories
Ethics Boards at Three Hospitals in Germany Approve Trial Expansion NEW YORK, May 21, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Photodynamic therapy with PHOTOFRIN® being studied in range of cancers OAKVILLE, ON, May 7, 2015 /PRNewswire/ - Concordia Healthcare Corp.
NEW YORK, April 21, 2015 /PRNewswire/ -- Delcath Systems, Inc.
LONDON, April 2, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015" provides data
Single-center, retrospective study evaluates Hepatic Progression Free Survival and Overall Survival after Regional Therapy NEW YORK, March 27, 2015 /PRNewswire/ -- Delcath Systems,
NEW YORK, March 9, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Research Presented at 2015 Gastrointestinal Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence in Elucidating Disease Biology and Identifying Potential Treatment Options
University of Mannheim Medical Center is first site opened TORONTO and CHICAGO, Oct.
TORONTO AND CHICAGO, Sept. 2, 2014 /PRNewswire/ - Concordia Healthcare Corp.
The Chinese liver fluke (Clonorchis sinensis) is a species of parasitic worm that is classified within the Platyhelminthes phylum. It can be found in Southeast Asia, Taiwan, Japan, and China and is present in nearly 30,000,000 humans today. It is thought to be one of the world’s most pervading parasites. The Chinese liver fluke requires two intermediate, or secondary, hosts and one definitive, or main, host to successfully complete its lifecycle. The first intermediate host is typically...
- A handkerchief.
- Specifically— The legendary sweat-cloth; the handkerchief of St. Veronica, according to tradition miraculously impressed with the mask of Christ; also, the napkin about Christ's head (Johu xx. 7).
- In general, any miraculous portrait of Christ.